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SUPPLEMENTARY NOTES
14. ABSTRACT-Shortly after return from Gulf War (GW) deployment in 1991, some GW veterans began reporting a constellation of health symptoms that did not meet criteria for well-defined medical conditions or syndromes. Symptoms included pain, cognitive deficits, skin rash, gastrointestinal difficulties and sleep problems. The initial attempts at identifying case definition used a one-time cross-sectional health symptom report, which is insufficient for determining a case definition given that symptoms often show remitting and relapsing tendencies. Current estimates suggest that 25 percent of GW veterans (nearly 170,000) have reported persisting multisymptom illness and in order to stimulate more appropriate treatment avenues for ill veterans, it is essential that a refined case definition be found taking change over time into account and examining the impact of symptoms previously reported on current health status. This will be accomplished by employing a longitudinal design with a large longitudinally followed cohort. Current health symptom survey data will therefore be compared with prior survey data. The practical application of this study is to provide a gold standard definition to be used in future treatment trials. The study goals include, devising a new case definition for GW illness, where possible assisting in the management of specific disease states, and collecting outcome data about treatment avenues employed and their efficacy. Year 1 goals have primarily been met including designed a web based health symptom to correspond with prior pen and pencil formats and obtaining necessary IRB and human use approvals to begin survey recruitment efforts. • IRB approval has been obtained from the VA Boston Healthcare System Institutional Review Board, Boston University School of Medicine, and HRPO.
Task 1 b. Receive health symptom comparison data from Ft. Devens Cohort Studies Time 1, 2, and 3.
• The PI has obtained access to the database stored behind the VA firewall at the VA Boston Healthcare System.
Task 1 c. Identify current address and contact information for surviving members of the Time I cohort of 2,949 participants.
• Addresses from study participants have been gathered from the last set of Ft. Devens surveys collected in 2004. Study personnel have begun checking contact information.
Months 4-9: Finalize Methods for Web Survey Design
Task 2 a. Format completed health symptom questionnaires for use with Teleform and website
• Questionnaires have been formatted for web conversion and paper questionnaires were programmed into web format to ensure a consistent and complete dataset for this fourth health symptom survey of the Ft. Devens cohort.
Task 2 b. Create website for collection of current health symptom status, health care utilization and treatment usage using web based programming.
• The PI and BU Site PI have met regularly with the BU data coordinating center staff (DCC) to discuss ways to implement the online survey and initial programming is completed. Study personnel have recently been piloting the web survey for implementation with study participants.
Months 9-36: Data Collection and Deliverables Task 3 a. Send pre-survey letter to original cohort participants with an "opt-out" postcard for those not wishing to participate.
• Presurvey letters will be sent shortly when the web survey questionnaire has been fully tested and is ready for implementation.
Task 3 b. Obtain demographic information and information pertaining to current health status and changes in medical or psychiatric diagnoses by use of web-based survey and by mail questionnaire for those individuals who do not have access to a computer.
• The web survey will be implemented in the first quarter of year 2 after all contact information has been obtained from study participants and the opt-out postcards have been returned.
Task 3 c. Follow-up calls made to individuals who have not responded. Complete health questionnaires on the phone for individuals not otherwise able to participate.
• Follow-up calls with study participants who have not responded will occur in the second quarter of year 2 and proceed until recruitment is complete.
Task 4 d. Data cleaning and preliminary analyses will be ongoing as data is collected in order to formulate an advanced algorithm case definition for GW Illness, an assessment of current health care utilization and treatment efficacy.
• Preliminary data analysis will begin in quarter 3 of year 2 and proceed throughout the rest of the study funding period as web survey data is collected.
Key Research Accomplishments:
• IRB approvals were obtained and initial human use was approved for this study protocol.
• Written questionnaires that have been used for prior Ft. Devens survey studies have been converted into web format for initiation of the web survey. Special care has been taken to ensure ease of self-administration for the internet based survey.
• Potential study participants have been identified from the Ft Devens cohort, those previously surveyed upon arriving home from deployment to the Gulf War.
• Randomized code numbers were generated for each potential survey participant to have a de-identified code number when completing the web survey.
• Longitudinal health symptom data has been collected from prior surveys and entered into a database that will allow for combination with subsequently collected data (Time 4).
• Study participant reimbursement codes for Amazon.com have been obtained to compensate participants for study participation.
Reportable Outcomes:
Presentations Krengel, M., Janulewicz, P., Chamberlian, J., Yuan, J. • Krengel, Sullivan et al., Chronic Health Symptoms in Military Pesticide Applicators from Gulf War I.
• Janulewicz-Lloyd, Sullivan, Krengel et al., Gulf War Illness: A meta-analytic review of cognitive findings.
• Sullivan, Krengel, Janulewicz-Lloyd et al., Gulf War Illness: A meta-analytic review of health symptom report findings.
Grant funding
Dr. Krengel and Dr. Sullivan have recently applied for three Gulf War-related grants as either PI or as collaborators with other GW investigators. All three proposals were recommended for grant funding and are listed below. Title: Identification of Plasma Biomarkers of Gulf War Illness Using "omic" Technology" (PI:Crawford; Co-I Krengel) Supporting Agency: CSR&D (CX000469-01A1) Specific aims: The aim of this project is to develop a plasma biomarker panel by using targeted "omic" investigations and screening an additional GW Veteran population to qualify the biomarker findings from the discovery phase by determining the reproducibility of the diagnostic specificity and sensitivity of the candidate biomarkers under investigation. This novel and innovative proposal addresses many of the outstanding needs pertaining to issues related to GWI, a) diagnostic biomarkers, b) differences in biological responses due to genetic heterogeneity, c) personalized medicine. Biomarkers may also be identified which can be used as surrogates for evaluation of therapeutic efficacy.
Title: Brain Immune Interactions as the Basis of Gulf War Illness: Gulf War Illness Consortium (GWIC) (PI: Sullivan, Co-I Krengel) Supporting agency: Department of Defense (CDMRP/GWIRP GW120037) Specific aims: This multisite consortium will undertake a coordinated series of clinical and preclinical studies aimed at providing a comprehensive understanding of the pathobiology of GWI. This will include clinical studies conducted in parallel at three sites (Boston, Miami, and Central Texas) that will collect data on veterans with GWI and healthy controls that includes brain imaging, neuropsychological testing, and diverse immune and genetic measures. Parallel preclinical studies will evaluate persistent effects of GW neurotoxicants in vitro and in rodent models of GWI. Findings from clinical and preclinical studies will be compared and used to identify specific brain-immune pathways that can be targeted for treatment intervention.
Conclusions to date:
This study has the unique potential of using longitudinal health symptom reports to compare trajectories of health symptoms over time in ill Gulf War veterans over a 20-year time span. This will not only provide the ability to further understand health symptom trajectories over time but will also allow for the determination of a newly revised case definition of GW illness. Accomplishments to date have included modernizing health survey techniques for ease of administration with secure web-based technologies. This will also reduce the time burden on participants as skip codes for non-relevant follow-up questions are now included. The web survey programming is now complete and is being tested by research personnel before going live with study participants. We do not anticipate problems with recruitment of participants from this prospectively followed longitudinal cohort of Gulf War veterans.
